PLRX icon

Pliant Therapeutics

151 hedge funds and large institutions have $725M invested in Pliant Therapeutics in 2024 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 60 increasing their positions, 31 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding:

0% more funds holding in top 10

Funds holding in top 10: 55 (0)

1.48% less ownership

Funds ownership: 105.91%104.43% (-1.5%)

74% less call options, than puts

Call options by funds: $1.3M | Put options by funds: $4.99M

Holders
151
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
5
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.3M
Puts
$4.99M
Net Calls
Net Calls Change

Top Buyers

1 +$34.8M
2 +$6.25M
3 +$3.36M
4
BlackRock
BlackRock
New York
+$2.77M
5
ACM
ADAR1 Capital Management
Texas
+$2.65M

Top Sellers

1 -$26.9M
2 -$10.8M
3 -$9.26M
4
GPP
Great Point Partners
Connecticut
-$8.15M
5
Citadel Advisors
Citadel Advisors
Florida
-$4.44M
Name Holding Trade Value Shares
Change
Change in
Stake
76
$523K
77
$519K
78
$519K
79
$498K
80
$479K
81
$456K
82
$446K
83
$408K
84
$393K
85
$388K
86
$386K
87
$368K
88
$351K
89
$342K
90
$342K
91
$296K
92
$287K
93
$271K
94
$254K
95
$249K
96
$242K
97
$193K
98
$181K
99
$178K
100
$164K